User: Guest  Login
Title:

Catumaxomab Administered as a 3-hour Infusion - Results From a Newly Integrated Safety Analysis Comprising 7 Clinical Studies

Document type:
Meeting Abstract
Author(s):
Finas, D; Schmalfeldt, B; Schilling, J; Oettle, H; Hennig, M; Ligensa, T; Schlegel, C; Seimetz, D; Kainz, A
Journal title abbreviation:
Eur J Cancer
Year:
2011
Journal volume:
47 1
Pages contribution:
S537-S537
Language:
eng
Print-ISSN:
0959-8049
TUM Institution:
Frauenklinik und Poliklinik
 BibTeX